Literature DB >> 17512248

Early and late results of combined mitral-aortic valve surgery.

K A Connelly1, L Creati, W Lyon, M Yii, A Rosalion, A C Wilson, J Santamaria, V M Jelinek.   

Abstract

OBJECTIVE: This retrospective study was designed to assess the early morbidity and mortality as well as long-term mortality of combined aortic-mitral valve procedures at a single centre.
METHODS: Patients were identified by analysing the intensive care and perfusion databases, from 1989 to 2003, with 113 receiving aortic-mitral valve procedures. Eighty-four percent of patients received a mechanical bileaflet valve. Survival was assessed using a Kaplan-Meier method, and determinants of survival with the Cox proportional hazards model.
RESULTS: There were 57 men and 56 women, median age 59 (18-84) years. The 30-day mortality was 9% (n=10). This cohort contained a number of high risk patients, 38% were classified as New York Heart Association class IV, 33.5% had at least moderate ventricular impairment, 20% were redo procedures and 17% urgent procedures. Survival estimates at 5 and 10 years were 85% (0.76-0.90) and 65% (0.49-0.77), respectively. Multivariate pre-operative predictors of death included renal dysfunction (creatinine >200 micromol/L) and hypertension. Rheumatic aetiology was associated with improved survival.
CONCLUSION: This study shows acceptable short and long-term survival in patients undergoing combined aortic-mitral valve surgical procedures at a single centre. Renal impairment and hypertension were associated with a poorer long-term prognosis and rheumatic aetiology was associated with improved survival. Age, LVEF and NYHA class were not associated with a worse outcome. This may affect future decision making in light of an aging population.

Entities:  

Mesh:

Year:  2007        PMID: 17512248     DOI: 10.1016/j.hlc.2007.03.015

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  5 in total

Review 1.  The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis.

Authors:  Sarah E Siegelaar; Maartje Hickmann; Joost B L Hoekstra; Frits Holleman; J Hans DeVries
Journal:  Crit Care       Date:  2011-09-13       Impact factor: 9.097

2.  Should high risk patients with concomitant severe aortic stenosis and mitral valve disease undergo double valve surgery in the TAVR era?

Authors:  Pey-Jen Yu; Allan Mattia; Hugh A Cassiere; Rick Esposito; Frank Manetta; Nina Kohn; Alan R Hartman
Journal:  J Cardiothorac Surg       Date:  2017-12-29       Impact factor: 1.637

3.  In-hospital outcomes of patients undergoing concomitant aortic and mitral valve replacement in Germany.

Authors:  Maximilian Kreibich; Klaus Kaier; Constantin von Zur Mühlen; Matthias Siepe; Manfred Zehender; Christoph Bode; Friedhelm Beyersdorf; Peter Stachon; Wolfgang Bothe
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-02-21

Review 4.  Multivalvular Disease: Percutaneous Management in 2019 and Beyond.

Authors:  Magdalena Erlebach; Rüdiger Lange
Journal:  Interv Cardiol       Date:  2019-11-18

5.  Combined Mitral and Aortic Valve Surgery: 17-year Experience in a Single Center.

Authors:  Annastiina Husso; Teemu Riekkinen; Aino Rissanen; Juho Ollila; Antti Valtola
Journal:  Scand J Surg       Date:  2021-01-18       Impact factor: 2.360

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.